Your Web Site
Ex-secretary asked if use would continue Audrey Hudson and Jen Haberkorn Wednesday, July 9, 2008 contacted colleagues at his old agency as the chief lobbyist for drug maker Pfizer Inc. earlier this year, looking for updates on whether his company's smoking-cessation drug Chantix would remain on the VA's list of approved prescription drugs amid new warnings of dangerous side effects. The government had just banned Chantix for use by pilots and air traffic controllers because of potential side effects on alertness and motor skills and had more broadly warned that the medicine could cause depression, suicidal thoughts and attempted suicide. Pfizer wanted insight on the VA's intent for the drug, which has been prescribed to thousands of veterans. Pfizer officials maintain that Mr. Principi's contacts at his old agency did not... [read full story]
|
FULL COVERAGE
|
|
Quiet investigation preceded warnings by months Audrey Hudson and Amy Fagan Tuesday, July 8, 2008 EXCLUSIVE: Department of Veterans Affairs doctors began raising red flags last year about whether the smoking-cessation drug...
The Department of Veterans Affairs (VA) was warned by its own doctors in 2007 that some veterans using the smoking cessation drug Chantix had experienced psychotic episodes and other bizarre behavior. Yet it wasn’t until last...
VA Secretary To Appear Before Congress Tomorrow By MADDY SAUER and VIC WALTER The Secretary of the Department of Veterans Affairs will appear before Congress tomorrow to answer questions about why his administration continued...
A lobbyist for Pfizer - once the head of the Department of Veteran’s Affairs (VA) - contacted his old agency about keeping Chantix on its drug formulary, even after the smoking cessation drug was linked to suicides. According...
Posted on: Wednesday, 9 July 2008, 12:00 CDT WASHINGTON, July 9 /PRNewswire-USNewswire/ -- In a congressional hearing Secretary of Veterans Affairs James B. Peake, M.D., discussed the safety and importance of the research...
Move Follows an ABC News/ Washington Times Investigation By AARON KATERSKY and RYAN SIBLEY The Department of Veterans Affairs promised today to review drug protocols for combat veterans with Post-Traumatic Stress Disorder. The...
Former Veterans Affairs Secretary Anthony Principi contacted colleagues at his old agency as a lobbyist for Pfizer earlier this year, seeking updates on whether Chantix would remain on the VA's list of approved prescription...
The secretary of the Department of Veterans Affairs plans to review drug protocols for treating patients with post-traumatic stress disorder (PTSD) after an investigation found it took his agency three months to alert its...
Peake awaits review, vows accountability Audrey Hudson and Jen Haberkorn Thursday, July 10, 2008 Department of Veterans Affairs watchdogs have concluded that the department failed to alert veterans suffering from post-traumatic...
Following revelations that it enrolled combat veterans with Post Traumatic Stress Disorder (PTSD) in a Chantix trial without warning participants of the drugs’ suicide risks, the Department of Veterans Affairs is now reviewing...
George W. Bush, Mental Health & Behavior, Post-Traumatic Stress Disorder, Suicide, Pfizer

